Supported self-management
Ensure your patient understands that effective home management of symptoms greatly improves outcome. Encourage daily self-monitoring, e.g., checking and recording peak expiratory flow (PEF) using a peak flow meter. When the patient discusses these results with you, subsequent adjustment of medications can be made. Emphasise that attending follow-up is essential for a long and healthy life with asthma. Always check the patient is using medications and delivery devices correctly.
The use of a written, personalised asthma action plan should be strongly encouraged to support self-management.[1]Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. 2024 [internet publication].
https://ginasthma.org/reports
[55]British Thoracic Society; Scottish Intercollegiate Guidelines Network. British guideline on the management of asthma: a national clinical guideline. Jul 2019 [internet publication].
https://www.sign.ac.uk/sign-158-british-guideline-on-the-management-of-asthma
[56]National Institute for Health and Care Excellence. Asthma: diagnosis, monitoring and chronic asthma management. Mar 2021 [internet publication].
https://www.nice.org.uk/guidance/ng80
[147]Ring N, Malcolm C, Wyke S, et al. Promoting the use of personal asthma action plans: a systematic review. Prim Care Respir J. 2007 Oct;16(5):271-83.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6634230
http://www.ncbi.nlm.nih.gov/pubmed/17710351?tool=bestpractice.com
Asthma and Lung UK: adult asthma action plan
Opens in new window The asthma action plan can help your patient to recognise when their asthma is deteriorating and how to respond appropriately: for example, increasing usual reliever and controller treatment, and determining when to seek medical help.[1]Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. 2024 [internet publication].
https://ginasthma.org/reports
[85]Gatheral TL, Rushton A, Evans DJ, et al. Personalised asthma action plans for adults with asthma. Cochrane Database Syst Rev. 2017 Apr 10;(4):CD011859.
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011859.pub2/full
http://www.ncbi.nlm.nih.gov/pubmed/28394084?tool=bestpractice.com
[
]
What are the effects of personalized asthma action plans in adults with mild, moderate, or severe asthma?/cca.html?targetUrl=https://cochranelibrary.com/cca/doi/10.1002/cca.1796/fullShow me the answer
[
]
For people with asthma, how does shared decision-making affect outcomes?/cca.html?targetUrl=https://cochranelibrary.com/cca/doi/10.1002/cca.1926/fullShow me the answer
Proactively address common barriers to adherence. These are often driven by lack of disease education (e.g., not knowing when to take medication; lack of belief that medication will improve asthma control).[148]Riley IL, Jackson B, Crabtree D, et al. A scoping review of international barriers to asthma medication adherence mapped to the theoretical domains framework. J Allergy Clin Immunol Pract. 2021 Jan;9(1):410-8.e4.
http://www.ncbi.nlm.nih.gov/pubmed/32861047?tool=bestpractice.com
Strategies including text/audiovisual message reminders, written action plans, and motivational interviewing may improve inhaler adherence.[149]van de Hei SJ, Dierick BJH, Aarts JEP, et al. Personalized medication adherence management in asthma and chronic obstructive pulmonary disease: a review of effective interventions and development of a practical adherence toolkit. J Allergy Clin Immunol Pract. 2021 Nov;9(11):3979-94.
https://www.doi.org/10.1016/j.jaip.2021.05.025
http://www.ncbi.nlm.nih.gov/pubmed/34111571?tool=bestpractice.com
Enhanced support may be required for patients transitioning into adulthood, as some studies report reduced adherence in patients aged >18 years.[150]Murphy J, McSharry J, Hynes L, et al. Prevalence and predictors of adherence to inhaled corticosteroids in young adults (15-30 years) with asthma: a systematic review and meta-analysis. J Asthma. 2021 May;58(5):683-705.
http://www.ncbi.nlm.nih.gov/pubmed/31906744?tool=bestpractice.com
Telemedicine appears to be effective at improving asthma control and quality of life in adults with asthma.[151]Chongmelaxme B, Lee S, Dhippayom T, et al. The effects of telemedicine on asthma control and patients' quality of life in adults: a systematic review and meta-analysis. J Allergy Clin Immunol Pract. 2019 Jan;7(1):199-216.
http://www.ncbi.nlm.nih.gov/pubmed/30055283?tool=bestpractice.com
eHealth interventions are effective at improving adherence to inhaled corticosteroid, particularly mobile device-based studies that include audiovisual and text message reminders.[152]Jeminiwa R, Hohmann L, Qian J, et al. Impact of eHealth on medication adherence among patients with asthma: a systematic review and meta-analysis. Respir Med. 2019 Mar;149:59-68.
https://www.resmedjournal.com/article/S0954-6111(19)30047-2/fulltext
http://www.ncbi.nlm.nih.gov/pubmed/30803887?tool=bestpractice.com
Digital health technology that includes interactive features, such as daily diary entries, is associated with increased asthma control; the same is true for multidimensional interventions that combine several different types of digital health technology.[153]Unni E, Gabriel S, Ariely R. A review of the use and effectiveness of digital health technologies in patients with asthma. Ann Allergy Asthma Immunol. 2018 Dec;121(6):680-91.
https://www.annallergy.org/article/S1081-1206(18)31314-0/fulltext
http://www.ncbi.nlm.nih.gov/pubmed/30352288?tool=bestpractice.com
Pharmacist-led interventions can also improve inhaler technique and medication adherence in adults with asthma.[154]Mes MA, Katzer CB, Chan AHY, et al. Pharmacists and medication adherence in asthma: a systematic review and meta-analysis. Eur Respir J. 2018 Aug 23;52(2):1800485.
https://erj.ersjournals.com/content/52/2/1800485.long
http://www.ncbi.nlm.nih.gov/pubmed/29976652?tool=bestpractice.com
[155]Jia X, Zhou S, Luo D, et al. Effect of pharmacist-led interventions on medication adherence and inhalation technique in adult patients with asthma or COPD: a systematic review and meta-analysis. J Clin Pharm Ther. 2020 Oct;45(5):904-17.
https://www.doi.org/10.1111/jcpt.13126
http://www.ncbi.nlm.nih.gov/pubmed/32107837?tool=bestpractice.com
Modifiable risk factors
Discuss environmental control strategies, including identifying and eliminating exposure (indoor or outdoor, e.g., at home or work) to allergens and irritants that can cause or worsen asthma, including house-dust mites, animals, cigarette smoke and other respiratory irritants, chemicals, and pollens and grasses.[1]Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. 2024 [internet publication].
https://ginasthma.org/reports
If you suspect an occupational cause, see Occupational asthma. Guidelines vary in their recommendations regarding allergen mitigation, so consult local guidance to inform the discussion with your patient.
Give advice about non-pharmacological therapies and strategies when appropriate (e.g., physical activity, weight loss, avoidance of triggers).[55]British Thoracic Society; Scottish Intercollegiate Guidelines Network. British guideline on the management of asthma: a national clinical guideline. Jul 2019 [internet publication].
https://www.sign.ac.uk/sign-158-british-guideline-on-the-management-of-asthma
Help the patient identify foods they are sensitive to and should therefore avoid. Counsel the patient about the dangers of smoking and second-hand tobacco smoke exposure, and offer support to stop smoking. Direct or passive exposure to cigarette smoke adversely affects quality of life, lung function, need for rescue medications for acute episodes of asthma, and long-term control with inhaled corticosteroids.[55]British Thoracic Society; Scottish Intercollegiate Guidelines Network. British guideline on the management of asthma: a national clinical guideline. Jul 2019 [internet publication].
https://www.sign.ac.uk/sign-158-british-guideline-on-the-management-of-asthma
If the patient is overweight, encourage them to lose weight via weight loss interventions, including dietary and exercise-based programmes.[55]British Thoracic Society; Scottish Intercollegiate Guidelines Network. British guideline on the management of asthma: a national clinical guideline. Jul 2019 [internet publication].
https://www.sign.ac.uk/sign-158-british-guideline-on-the-management-of-asthma
Also counsel your patient about avoiding specific drugs (e.g., aspirin and non-steroidal anti-inflammatory drugs, beta-blockers) where necessary, and treatment of comorbidities (e.g., gastro-oesophageal reflux, infections).[1]Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. 2024 [internet publication].
https://ginasthma.org/reports
Immunisation
Vaccination schedules vary by location; consult local guidance for recommendations. Further information on UK and US vaccines, and special patient populations, can be found in their respective vaccination schedules.
UKHSA: complete routine immunisation schedule
Opens in new window
CDC: ACIP recommendations
Opens in new window See Secondary prevention.
Mental health
Make mental health referrals where necessary. Patients with asthma are at risk of depression and anxiety; drug treatment and cognitive behaviour therapy may be suitable, although evidence is limited.[1]Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. 2024 [internet publication].
https://ginasthma.org/reports
Patients with asthma have a significantly increased risk of suicidal ideation, suicide attempts, and suicide mortality.[117]National Institute for Health and Care Excellence. Reslizumab for treating severe eosinophilic asthma. Oct 2017 [internet publication].
https://www.nice.org.uk/guidance/ta479
Inhaler choice
Consider patient concerns about inhaler choice, including environmental issues.
Asthma and Lung UK: inhaler use and choices
Opens in new window[156]Ten Have P, van Hal P, Wichers I, et al. Turning green: the impact of changing to more eco-friendly respiratory healthcare - a carbon and cost analysis of Dutch prescription data. BMJ Open. 2022 Jun 14;12(6):e055546.
https://bmjopen.bmj.com/content/12/6/e055546.long
http://www.ncbi.nlm.nih.gov/pubmed/35701064?tool=bestpractice.com